Crescita Therapeutics (Crescita Therapeutics) Pretax Margin % : 0.99% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Crescita Therapeutics's Pre-Tax Income for the three months ended in Dec. 2023 was $0.04 Mil. Crescita Therapeutics's Revenue for the three months ended in Dec. 2023 was $3.52 Mil. Therefore, Crescita Therapeutics's pretax margin for the quarter that ended in Dec. 2023 was 0.99%.

The historical rank and industry rank for Crescita Therapeutics's Pretax Margin % or its related term are showing as below:

CRRTF' s Pretax Margin % Range Over the Past 10 Years
Min: -3274.12 Med: -7.38 Max: 14.24
Current: -8.73

CRRTF's Pretax Margin % is ranked worse than
68.3% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 4.555 vs CRRTF: -8.73

Crescita Therapeutics Pretax Margin % Historical Data

The historical data trend for Crescita Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Pretax Margin % Chart

Crescita Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pretax Margin %

Get a 7-Day Free Trial

14.24

3.33

-6.01

1.72

-8.73

Crescita Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pretax Margin %	Get a 7-Day Free Trial															11.94	-2.32	-3.66	-42.24	0.99

Competitive Comparison of Crescita Therapeutics's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Crescita Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Crescita Therapeutics's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Crescita Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Crescita Therapeutics's Pretax Margin % falls into.

Crescita Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Crescita Therapeutics's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1.14	/	13.061
	=	-8.73 %

Crescita Therapeutics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0.035	/	3.522
	=	0.99 %

Crescita Therapeutics (OTCPK:CRRTF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Crescita Therapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Crescita Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescita Therapeutics (Crescita Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (OTCPK:CRRTF) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

CTX:Canada

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue in the form of product sales and out-licensing revenue.